29/2/2024
to
1/3/2024
London
Advancing precision medicine through cutting-edge biomarker research and applications.
Accelerate your design, make, test cycle with leading in vitro ADME & in vivo DMPK
This week (31 March 2025) marks two years since Concept Life Sciences came under Limerston Capital ownership.
Find out about our solid-phase peptide synthesis expertise.
Concept Life Sciences is delighted to be shortlisted for the Bionow Technical Service Award
Concept Life Sciences is delighted to announce that we have achieved Cyber Essentials Plus certification.